In: PATENT NEWS
Exelixis, Inc. Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc. Yahoo Finance
In: PATENT NEWS
Exelixis, Inc. Announces Settlement of CABOMETYX® (cabozantinib … Business Wire
In: The IPKat BLOG
http://ipkitten.blogspot.com/2023/07/never-too-late-if-you-missed-ipkat-last_23.html Image credits: Riana Harvey Had no time to focus on the latest IP developments last week? IPKat understands your busy schedule and brings you a brief summary of what recently happened in the IP news in its weekly Never Too Late post. Trademarks Anna Maria Stein analyzed the decision... Continue reading
In: COPYRIGHT NEWS
Copyright commission to partner creative agencies in correctional … Voice of Nigeria
In: PATENT NEWS
Hamza Adam, are quick to invoke the very law of which they have made … would not have learned about this patent act of wanton corruption, …
In: PATENT NEWS
Patent and trademark – Priority dates – Continuity of disclosure … Insurance – Standing – Medicare Secondary Payer Act.
In: TRADEMARK NEWS
Patent and trademark – Priority dates – Continuity of disclosure Massachusetts Lawyers Weekly
In: TRADEMARK NEWS
5 Trademarks of a Molly Brandt Show Music in Minnesota
In: PATENT NEWS
What are compulsory licences? Compulsory licenses are a measure established in intellectual property legislation that allows a country’s government to …
In: PATENT NEWS
The court ruled that in the issues pertaining to rights of patentees, the Patents Act overrides the Competition Act and hence the anti-trust regulator …
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION